Mittie Doyle

AVTX

Mittie Doyle serves as officer: Chief Medical Officer at Avalo Therapeutics, Inc. (AVTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

12 trades

$2.97M

Net Position

Net Seller

$2.97M

Companies Traded

AVTX

Active Period

Dec 2025 – Sep 2026

12 total trades

Most Recent

Sell AVTX

Sep 1, 2026 · $13.6K

Mittie Doyle's Insider Trading at Avalo Therapeutics, Inc. (AVTX)

Buys

0 · $0.00

Sells

12 · $2.97M

Total Shares Bought

Total Shares Sold

151,850

AVTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 1, 2026	Sell	679	$20.00	$13.6K	51,776
Aug 19, 2026	Sell	1,000	$20.00	$20.0K	51,776
Aug 12, 2026	Sell	679	$20.00	$13.6K	51,776
Jul 29, 2026	Sell	1,000	$20.00	$20.0K	51,776
Jul 2, 2026	Sell	4,654	$20.00	$93.1K	51,776
Jun 25, 2026	Sell	1,450	$18.00	$26.1K	51,776
Jun 1, 2026	Sell	679	$16.00	$10.9K	47,122
May 19, 2026	Sell	3,000	$18.76	$56.3K	3,622
May 7, 2026	Sell	108,234	$20.61	$2.23M	82,639
Apr 8, 2026	Sell	3,970	$18.01	$71.5K	3,622
Mar 18, 2026	Sell	25,492	$16.15	$411.6K	3,622
Dec 10, 2025	Sell	1,013	$4.10	$4.2K	0